nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—CYP2B6—Memantine—Alzheimer's disease	0.289	0.494	CbGbCtD
Benzphetamine—CYP3A4—Rivastigmine—Alzheimer's disease	0.128	0.219	CbGbCtD
Benzphetamine—CYP3A4—Donepezil—Alzheimer's disease	0.102	0.175	CbGbCtD
Benzphetamine—CYP3A4—Galantamine—Alzheimer's disease	0.066	0.113	CbGbCtD
Benzphetamine—Cardiac valve disease—Memantine—Alzheimer's disease	0.0292	0.2	CcSEcCtD
Benzphetamine—SLC6A2—locus ceruleus—Alzheimer's disease	0.0204	0.186	CbGeAlD
Benzphetamine—SLC18A2—telencephalic ventricle—Alzheimer's disease	0.0159	0.144	CbGeAlD
Benzphetamine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.012	0.109	CbGeAlD
Benzphetamine—SLC18A2—forebrain—Alzheimer's disease	0.00414	0.0377	CbGeAlD
Benzphetamine—SLC18A2—telencephalon—Alzheimer's disease	0.00381	0.0347	CbGeAlD
Benzphetamine—Psychotic disorder—Donepezil—Alzheimer's disease	0.00375	0.0256	CcSEcCtD
Benzphetamine—Psychotic disorder—Memantine—Alzheimer's disease	0.0034	0.0233	CcSEcCtD
Benzphetamine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00333	0.0228	CcSEcCtD
Benzphetamine—SLC6A3—forebrain—Alzheimer's disease	0.00313	0.0285	CbGeAlD
Benzphetamine—SLC6A3—telencephalon—Alzheimer's disease	0.00288	0.0262	CbGeAlD
Benzphetamine—Sweating—Donepezil—Alzheimer's disease	0.00284	0.0194	CcSEcCtD
Benzphetamine—Tremor—Galantamine—Alzheimer's disease	0.00279	0.0191	CcSEcCtD
Benzphetamine—Agitation—Galantamine—Alzheimer's disease	0.00274	0.0188	CcSEcCtD
Benzphetamine—Palpitations—Galantamine—Alzheimer's disease	0.00264	0.018	CcSEcCtD
Benzphetamine—SLC6A2—forebrain—Alzheimer's disease	0.00253	0.023	CbGeAlD
Benzphetamine—Sweating—Rivastigmine—Alzheimer's disease	0.00252	0.0172	CcSEcCtD
Benzphetamine—Tachycardia—Galantamine—Alzheimer's disease	0.00238	0.0163	CcSEcCtD
Benzphetamine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00235	0.0161	CcSEcCtD
Benzphetamine—ADRA1A—forebrain—Alzheimer's disease	0.00235	0.0214	CbGeAlD
Benzphetamine—SLC6A2—telencephalon—Alzheimer's disease	0.00232	0.0212	CbGeAlD
Benzphetamine—Anorexia—Galantamine—Alzheimer's disease	0.00232	0.0159	CcSEcCtD
Benzphetamine—SLC18A2—nervous system—Alzheimer's disease	0.00225	0.0205	CbGeAlD
Benzphetamine—POR—cerebellum—Alzheimer's disease	0.00222	0.0202	CbGeAlD
Benzphetamine—Insomnia—Galantamine—Alzheimer's disease	0.0022	0.0151	CcSEcCtD
Benzphetamine—Tremor—Donepezil—Alzheimer's disease	0.00217	0.0148	CcSEcCtD
Benzphetamine—SLC18A2—central nervous system—Alzheimer's disease	0.00216	0.0197	CbGeAlD
Benzphetamine—ADRA1A—telencephalon—Alzheimer's disease	0.00216	0.0197	CbGeAlD
Benzphetamine—Dyspepsia—Galantamine—Alzheimer's disease	0.00214	0.0147	CcSEcCtD
Benzphetamine—Agitation—Donepezil—Alzheimer's disease	0.00212	0.0145	CcSEcCtD
Benzphetamine—Decreased appetite—Galantamine—Alzheimer's disease	0.00212	0.0145	CcSEcCtD
Benzphetamine—SLC18A2—cerebellum—Alzheimer's disease	0.00212	0.0193	CbGeAlD
Benzphetamine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.0021	0.0144	CcSEcCtD
Benzphetamine—Tremor—Memantine—Alzheimer's disease	0.00197	0.0135	CcSEcCtD
Benzphetamine—Agitation—Memantine—Alzheimer's disease	0.00193	0.0132	CcSEcCtD
Benzphetamine—Tremor—Rivastigmine—Alzheimer's disease	0.00192	0.0132	CcSEcCtD
Benzphetamine—Agitation—Rivastigmine—Alzheimer's disease	0.00189	0.0129	CcSEcCtD
Benzphetamine—Palpitations—Memantine—Alzheimer's disease	0.00185	0.0127	CcSEcCtD
Benzphetamine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00182	0.0125	CcSEcCtD
Benzphetamine—Palpitations—Rivastigmine—Alzheimer's disease	0.00181	0.0124	CcSEcCtD
Benzphetamine—POR—brain—Alzheimer's disease	0.0018	0.0164	CbGeAlD
Benzphetamine—Anorexia—Donepezil—Alzheimer's disease	0.0018	0.0123	CcSEcCtD
Benzphetamine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00179	0.0123	CcSEcCtD
Benzphetamine—ADRA2A—forebrain—Alzheimer's disease	0.00179	0.0163	CbGeAlD
Benzphetamine—SLC18A2—brain—Alzheimer's disease	0.00172	0.0157	CbGeAlD
Benzphetamine—Insomnia—Donepezil—Alzheimer's disease	0.00171	0.0117	CcSEcCtD
Benzphetamine—SLC6A3—nervous system—Alzheimer's disease	0.0017	0.0155	CbGeAlD
Benzphetamine—Tachycardia—Memantine—Alzheimer's disease	0.00167	0.0114	CcSEcCtD
Benzphetamine—Diarrhoea—Galantamine—Alzheimer's disease	0.00167	0.0114	CcSEcCtD
Benzphetamine—Dyspepsia—Donepezil—Alzheimer's disease	0.00166	0.0114	CcSEcCtD
Benzphetamine—Hyperhidrosis—Memantine—Alzheimer's disease	0.00166	0.0113	CcSEcCtD
Benzphetamine—ADRA2A—telencephalon—Alzheimer's disease	0.00164	0.015	CbGeAlD
Benzphetamine—Decreased appetite—Donepezil—Alzheimer's disease	0.00164	0.0112	CcSEcCtD
Benzphetamine—SLC6A3—central nervous system—Alzheimer's disease	0.00164	0.0149	CbGeAlD
Benzphetamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00164	0.0112	CcSEcCtD
Benzphetamine—Anorexia—Memantine—Alzheimer's disease	0.00163	0.0112	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00163	0.0111	CcSEcCtD
Benzphetamine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00162	0.0111	CcSEcCtD
Benzphetamine—Dizziness—Galantamine—Alzheimer's disease	0.00161	0.011	CcSEcCtD
Benzphetamine—SLC6A3—cerebellum—Alzheimer's disease	0.0016	0.0146	CbGeAlD
Benzphetamine—Anorexia—Rivastigmine—Alzheimer's disease	0.0016	0.0109	CcSEcCtD
Benzphetamine—Insomnia—Memantine—Alzheimer's disease	0.00155	0.0106	CcSEcCtD
Benzphetamine—Headache—Galantamine—Alzheimer's disease	0.00152	0.0104	CcSEcCtD
Benzphetamine—Insomnia—Rivastigmine—Alzheimer's disease	0.00152	0.0104	CcSEcCtD
Benzphetamine—Dyspepsia—Memantine—Alzheimer's disease	0.00151	0.0103	CcSEcCtD
Benzphetamine—Urticaria—Donepezil—Alzheimer's disease	0.0015	0.0103	CcSEcCtD
Benzphetamine—Decreased appetite—Memantine—Alzheimer's disease	0.00149	0.0102	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00148	0.0101	CcSEcCtD
Benzphetamine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00147	0.0101	CcSEcCtD
Benzphetamine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00146	0.00996	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00145	0.0099	CcSEcCtD
Benzphetamine—Nausea—Galantamine—Alzheimer's disease	0.00145	0.00989	CcSEcCtD
Benzphetamine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00139	0.00951	CcSEcCtD
Benzphetamine—SLC6A2—nervous system—Alzheimer's disease	0.00137	0.0125	CbGeAlD
Benzphetamine—Urticaria—Memantine—Alzheimer's disease	0.00136	0.00931	CcSEcCtD
Benzphetamine—Urticaria—Rivastigmine—Alzheimer's disease	0.00133	0.00911	CcSEcCtD
Benzphetamine—SLC6A2—central nervous system—Alzheimer's disease	0.00132	0.012	CbGeAlD
Benzphetamine—SLC6A3—brain—Alzheimer's disease	0.0013	0.0118	CbGeAlD
Benzphetamine—Diarrhoea—Donepezil—Alzheimer's disease	0.00129	0.00883	CcSEcCtD
Benzphetamine—ADRA1A—nervous system—Alzheimer's disease	0.00128	0.0116	CbGeAlD
Benzphetamine—Hypersensitivity—Memantine—Alzheimer's disease	0.00126	0.00863	CcSEcCtD
Benzphetamine—Dizziness—Donepezil—Alzheimer's disease	0.00125	0.00853	CcSEcCtD
Benzphetamine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00123	0.00845	CcSEcCtD
Benzphetamine—ADRA1A—central nervous system—Alzheimer's disease	0.00123	0.0112	CbGeAlD
Benzphetamine—ADRA1A—cerebellum—Alzheimer's disease	0.0012	0.0109	CbGeAlD
Benzphetamine—Headache—Donepezil—Alzheimer's disease	0.00118	0.00808	CcSEcCtD
Benzphetamine—Diarrhoea—Memantine—Alzheimer's disease	0.00117	0.00802	CcSEcCtD
Benzphetamine—Pargyline—MAOB—Alzheimer's disease	0.00116	0.0958	CrCbGaD
Benzphetamine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00115	0.00784	CcSEcCtD
Benzphetamine—Dizziness—Memantine—Alzheimer's disease	0.00113	0.00775	CcSEcCtD
Benzphetamine—Nausea—Donepezil—Alzheimer's disease	0.00112	0.00767	CcSEcCtD
Benzphetamine—Dizziness—Rivastigmine—Alzheimer's disease	0.00111	0.00758	CcSEcCtD
Benzphetamine—Headache—Memantine—Alzheimer's disease	0.00107	0.00734	CcSEcCtD
Benzphetamine—Headache—Rivastigmine—Alzheimer's disease	0.00105	0.00718	CcSEcCtD
Benzphetamine—SLC6A2—brain—Alzheimer's disease	0.00105	0.00955	CbGeAlD
Benzphetamine—Nausea—Memantine—Alzheimer's disease	0.00102	0.00696	CcSEcCtD
Benzphetamine—CYP2B6—nervous system—Alzheimer's disease	0.00101	0.00921	CbGeAlD
Benzphetamine—Nausea—Rivastigmine—Alzheimer's disease	0.000995	0.00681	CcSEcCtD
Benzphetamine—ADRA1A—brain—Alzheimer's disease	0.000975	0.00888	CbGeAlD
Benzphetamine—CYP2B6—central nervous system—Alzheimer's disease	0.000973	0.00887	CbGeAlD
Benzphetamine—ADRA2A—nervous system—Alzheimer's disease	0.00097	0.00884	CbGeAlD
Benzphetamine—ADRA2A—central nervous system—Alzheimer's disease	0.000933	0.00851	CbGeAlD
Benzphetamine—ADRA2A—cerebellum—Alzheimer's disease	0.000912	0.00831	CbGeAlD
Benzphetamine—CYP2B6—brain—Alzheimer's disease	0.000773	0.00704	CbGeAlD
Benzphetamine—CYP3A4—nervous system—Alzheimer's disease	0.000763	0.00695	CbGeAlD
Benzphetamine—ADRA2A—brain—Alzheimer's disease	0.000741	0.00675	CbGeAlD
Benzphetamine—CYP3A4—central nervous system—Alzheimer's disease	0.000735	0.0067	CbGeAlD
Benzphetamine—Bepridil—CALM1—Alzheimer's disease	0.000709	0.0587	CrCbGaD
Benzphetamine—Trimethaphan—BCHE—Alzheimer's disease	0.000618	0.0512	CrCbGaD
Benzphetamine—Selegiline—MAOB—Alzheimer's disease	0.000578	0.0478	CrCbGaD
Benzphetamine—Phenoxybenzamine—CALM1—Alzheimer's disease	0.000552	0.0457	CrCbGaD
Benzphetamine—Atomoxetine—HTR6—Alzheimer's disease	0.000517	0.0428	CrCbGaD
Benzphetamine—Amphetamine—MAOB—Alzheimer's disease	0.00048	0.0398	CrCbGaD
Benzphetamine—Toremifene—ESR1—Alzheimer's disease	0.000461	0.0381	CrCbGaD
Benzphetamine—Oxaprozin—PTGS1—Alzheimer's disease	0.000459	0.038	CrCbGaD
Benzphetamine—Promethazine—CALM1—Alzheimer's disease	0.000454	0.0376	CrCbGaD
Benzphetamine—Methamphetamine—MAOB—Alzheimer's disease	0.000445	0.0368	CrCbGaD
Benzphetamine—Ethopropazine—BCHE—Alzheimer's disease	0.000394	0.0326	CrCbGaD
Benzphetamine—Phenylbutazone—PTGS1—Alzheimer's disease	0.000303	0.0251	CrCbGaD
Benzphetamine—Tripelennamine—CYP2D6—Alzheimer's disease	0.000285	0.0236	CrCbGaD
Benzphetamine—Oxaprozin—PTGS2—Alzheimer's disease	0.000262	0.0217	CrCbGaD
Benzphetamine—Cyclobenzaprine—HTR2A—Alzheimer's disease	0.000259	0.0214	CrCbGaD
Benzphetamine—Cyclobenzaprine—CYP2D6—Alzheimer's disease	0.000237	0.0196	CrCbGaD
Benzphetamine—Benzatropine—CYP2D6—Alzheimer's disease	0.000219	0.0181	CrCbGaD
Benzphetamine—Amphetamine—SLC6A4—Alzheimer's disease	0.000217	0.018	CrCbGaD
Benzphetamine—Methamphetamine—SLC6A4—Alzheimer's disease	0.000201	0.0167	CrCbGaD
Benzphetamine—Atomoxetine—SLC6A4—Alzheimer's disease	0.000198	0.0164	CrCbGaD
Benzphetamine—Propafenone—CYP2D6—Alzheimer's disease	0.000193	0.016	CrCbGaD
Benzphetamine—Dextroamphetamine—CYP2D6—Alzheimer's disease	0.000189	0.0157	CrCbGaD
Benzphetamine—Tamoxifen—ESR1—Alzheimer's disease	0.000184	0.0152	CrCbGaD
Benzphetamine—Selegiline—CYP2D6—Alzheimer's disease	0.000184	0.0152	CrCbGaD
Benzphetamine—Phenylbutazone—PTGS2—Alzheimer's disease	0.000173	0.0144	CrCbGaD
Benzphetamine—Bepridil—CYP2D6—Alzheimer's disease	0.000172	0.0142	CrCbGaD
Benzphetamine—Diphenhydramine—PTGS1—Alzheimer's disease	0.000165	0.0137	CrCbGaD
Benzphetamine—Trimipramine—SLC6A4—Alzheimer's disease	0.000163	0.0135	CrCbGaD
Benzphetamine—Dextropropoxyphene—CYP2D6—Alzheimer's disease	0.00016	0.0132	CrCbGaD
Benzphetamine—Amphetamine—CYP2D6—Alzheimer's disease	0.000153	0.0126	CrCbGaD
Benzphetamine—Atomoxetine—HTR2A—Alzheimer's disease	0.000152	0.0126	CrCbGaD
Benzphetamine—Methamphetamine—CYP2D6—Alzheimer's disease	0.000141	0.0117	CrCbGaD
Benzphetamine—Atomoxetine—CYP2D6—Alzheimer's disease	0.000139	0.0115	CrCbGaD
Benzphetamine—Trimipramine—HTR2A—Alzheimer's disease	0.000125	0.0104	CrCbGaD
Benzphetamine—Promethazine—HTR2A—Alzheimer's disease	0.000121	0.00998	CrCbGaD
Benzphetamine—Trimipramine—CYP2D6—Alzheimer's disease	0.000114	0.00947	CrCbGaD
Benzphetamine—Diphenhydramine—CYP2D6—Alzheimer's disease	0.000112	0.0093	CrCbGaD
Benzphetamine—Promethazine—CYP2D6—Alzheimer's disease	0.00011	0.00912	CrCbGaD
Benzphetamine—Tamoxifen—CYP2D6—Alzheimer's disease	0.000109	0.00906	CrCbGaD
Benzphetamine—Methadone—CYP2D6—Alzheimer's disease	0.000108	0.00898	CrCbGaD
Benzphetamine—Promazine—HTR2A—Alzheimer's disease	0.000106	0.00878	CrCbGaD
Benzphetamine—ADRA1A—Signaling Pathways—HTR6—Alzheimer's disease	4.68e-05	0.00032	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CRH—Alzheimer's disease	4.64e-05	0.000317	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—SST—Alzheimer's disease	4.62e-05	0.000316	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GAB2—Alzheimer's disease	4.62e-05	0.000316	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.57e-05	0.000312	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDK5—Alzheimer's disease	4.52e-05	0.000309	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—F2—Alzheimer's disease	4.52e-05	0.000309	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—SST—Alzheimer's disease	4.51e-05	0.000308	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GAB2—Alzheimer's disease	4.51e-05	0.000308	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—APP—Alzheimer's disease	4.5e-05	0.000308	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	4.48e-05	0.000307	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—APP—Alzheimer's disease	4.4e-05	0.000301	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—NPS—Alzheimer's disease	4.39e-05	0.0003	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	4.38e-05	0.0003	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	4.37e-05	0.000299	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR6—Alzheimer's disease	4.35e-05	0.000297	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PLAU—Alzheimer's disease	4.34e-05	0.000297	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CCL2—Alzheimer's disease	4.33e-05	0.000296	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—CALM1—Alzheimer's disease	4.3e-05	0.000294	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CHAT—Alzheimer's disease	4.27e-05	0.000292	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TPI1—Alzheimer's disease	4.27e-05	0.000292	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PSENEN—Alzheimer's disease	4.25e-05	0.000291	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.25e-05	0.00029	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—CAV1—Alzheimer's disease	4.24e-05	0.00029	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APH1A—Alzheimer's disease	4.19e-05	0.000287	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GAB2—Alzheimer's disease	4.19e-05	0.000287	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—SST—Alzheimer's disease	4.19e-05	0.000287	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PLCB1—Alzheimer's disease	4.15e-05	0.000284	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	4.12e-05	0.000281	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MAOB—Alzheimer's disease	4.1e-05	0.00028	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—APP—Alzheimer's disease	4.09e-05	0.000279	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NCSTN—Alzheimer's disease	4.08e-05	0.000279	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—F2—Alzheimer's disease	4.04e-05	0.000276	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CCL2—Alzheimer's disease	4.03e-05	0.000275	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TPI1—Alzheimer's disease	4.01e-05	0.000274	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CHAT—Alzheimer's disease	4.01e-05	0.000274	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NOS2—Alzheimer's disease	3.99e-05	0.000273	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LRP1—Alzheimer's disease	3.98e-05	0.000272	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PSENEN—Alzheimer's disease	3.95e-05	0.00027	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GAPDH—Alzheimer's disease	3.94e-05	0.00027	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APH1A—Alzheimer's disease	3.9e-05	0.000266	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GFAP—Alzheimer's disease	3.89e-05	0.000266	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GAL—Alzheimer's disease	3.89e-05	0.000266	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PLCB1—Alzheimer's disease	3.85e-05	0.000263	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MAOB—Alzheimer's disease	3.84e-05	0.000263	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—A2M—Alzheimer's disease	3.81e-05	0.00026	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NCSTN—Alzheimer's disease	3.79e-05	0.000259	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.73e-05	0.000255	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LRP1—Alzheimer's disease	3.7e-05	0.000253	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GAPDH—Alzheimer's disease	3.7e-05	0.000253	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GFAP—Alzheimer's disease	3.61e-05	0.000247	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GAL—Alzheimer's disease	3.61e-05	0.000247	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—A2M—Alzheimer's disease	3.57e-05	0.000244	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IGF1—Alzheimer's disease	3.54e-05	0.000242	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.5e-05	0.00024	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—A2M—Alzheimer's disease	3.43e-05	0.000234	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	3.41e-05	0.000233	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.38e-05	0.000231	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.32e-05	0.000227	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PSEN2—Alzheimer's disease	3.32e-05	0.000227	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ACHE—Alzheimer's disease	3.31e-05	0.000226	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—INPP5D—Alzheimer's disease	3.27e-05	0.000224	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	3.21e-05	0.000219	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	3.2e-05	0.000219	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	3.18e-05	0.000218	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.17e-05	0.000217	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.14e-05	0.000215	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.13e-05	0.000214	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ACHE—Alzheimer's disease	3.11e-05	0.000212	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ENO1—Alzheimer's disease	3.1e-05	0.000212	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	3.1e-05	0.000212	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	3.08e-05	0.000211	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	3.07e-05	0.00021	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	3.07e-05	0.00021	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	3.05e-05	0.000209	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	3.04e-05	0.000208	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.04e-05	0.000208	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	3.04e-05	0.000208	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	2.97e-05	0.000203	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	2.95e-05	0.000201	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.92e-05	0.0002	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.91e-05	0.000199	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ENO1—Alzheimer's disease	2.91e-05	0.000199	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	2.91e-05	0.000199	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	2.91e-05	0.000199	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—BCHE—Alzheimer's disease	2.89e-05	0.000197	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	2.86e-05	0.000196	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	2.85e-05	0.000195	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	2.85e-05	0.000195	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	2.85e-05	0.000194	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	2.84e-05	0.000194	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.82e-05	0.000193	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	2.82e-05	0.000193	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	2.79e-05	0.000191	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	2.78e-05	0.00019	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	2.75e-05	0.000188	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	2.74e-05	0.000187	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	2.74e-05	0.000187	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	2.72e-05	0.000186	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—BCHE—Alzheimer's disease	2.71e-05	0.000185	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	2.7e-05	0.000185	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	2.67e-05	0.000182	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	2.67e-05	0.000182	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	2.67e-05	0.000182	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	2.65e-05	0.000181	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	2.64e-05	0.000181	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	2.64e-05	0.000181	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	2.64e-05	0.00018	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	2.6e-05	0.000178	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	2.6e-05	0.000177	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	2.58e-05	0.000177	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	2.55e-05	0.000175	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	2.55e-05	0.000174	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	2.55e-05	0.000174	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	2.49e-05	0.000171	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	2.48e-05	0.000169	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	2.48e-05	0.000169	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	2.48e-05	0.000169	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	2.47e-05	0.000169	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	2.47e-05	0.000169	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	2.45e-05	0.000168	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	2.45e-05	0.000168	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	2.41e-05	0.000165	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	2.32e-05	0.000158	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	2.31e-05	0.000158	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	2.29e-05	0.000156	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	2.28e-05	0.000156	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	2.28e-05	0.000156	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	2.27e-05	0.000155	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	2.26e-05	0.000155	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	2.23e-05	0.000153	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	2.22e-05	0.000152	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	2.13e-05	0.000146	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	2.12e-05	0.000145	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	2.12e-05	0.000145	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	2.12e-05	0.000145	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	2.11e-05	0.000144	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	2.11e-05	0.000144	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	2.08e-05	0.000142	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—LPL—Alzheimer's disease	2.07e-05	0.000142	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	2.07e-05	0.000141	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	2.01e-05	0.000137	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	1.96e-05	0.000134	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	1.94e-05	0.000133	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—LPL—Alzheimer's disease	1.94e-05	0.000133	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	1.87e-05	0.000128	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	1.87e-05	0.000127	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	1.86e-05	0.000127	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	1.85e-05	0.000126	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.82e-05	0.000124	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.82e-05	0.000124	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	1.81e-05	0.000124	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	1.81e-05	0.000123	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	1.77e-05	0.000121	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	1.75e-05	0.00012	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	1.75e-05	0.000119	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.75e-05	0.000119	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	1.74e-05	0.000119	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOE—Alzheimer's disease	1.74e-05	0.000119	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	1.73e-05	0.000118	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	1.72e-05	0.000118	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	1.72e-05	0.000117	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	1.72e-05	0.000117	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	1.68e-05	0.000115	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	1.68e-05	0.000115	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.68e-05	0.000115	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	1.64e-05	0.000112	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	1.63e-05	0.000112	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOE—Alzheimer's disease	1.63e-05	0.000111	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.62e-05	0.000111	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	1.61e-05	0.00011	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	1.6e-05	0.000109	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	1.57e-05	0.000107	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	1.56e-05	0.000107	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	1.56e-05	0.000107	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	1.56e-05	0.000107	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	1.55e-05	0.000106	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	1.51e-05	0.000103	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	1.49e-05	0.000102	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—INS—Alzheimer's disease	1.48e-05	0.000101	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	1.47e-05	0.000101	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	1.47e-05	0.000101	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	1.46e-05	9.96e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	1.45e-05	9.92e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	1.45e-05	9.92e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.44e-05	9.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	1.44e-05	9.83e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	1.42e-05	9.69e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.41e-05	9.65e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.4e-05	9.54e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—INS—Alzheimer's disease	1.39e-05	9.51e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	1.39e-05	9.47e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	1.37e-05	9.36e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	1.35e-05	9.25e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	1.34e-05	9.18e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.34e-05	9.16e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	1.33e-05	9.12e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.32e-05	9.04e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.32e-05	9.04e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	1.31e-05	8.98e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	1.3e-05	8.89e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.3e-05	8.87e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.29e-05	8.83e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.26e-05	8.59e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.25e-05	8.53e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.24e-05	8.48e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.23e-05	8.4e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.22e-05	8.34e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	1.22e-05	8.34e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.2e-05	8.2e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.19e-05	8.13e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.17e-05	8e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.16e-05	7.93e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.12e-05	7.69e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.12e-05	7.62e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.09e-05	7.43e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1e-05	6.86e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	9.94e-06	6.79e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	9.87e-06	6.75e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	9.69e-06	6.63e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	9.65e-06	6.6e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	9.32e-06	6.37e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	9.23e-06	6.31e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	9.17e-06	6.27e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	9.13e-06	6.24e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	9.11e-06	6.23e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LPL—Alzheimer's disease	8.82e-06	6.03e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	8.49e-06	5.8e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	8.46e-06	5.79e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	8.43e-06	5.76e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	7.95e-06	5.43e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	7.84e-06	5.36e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	7.74e-06	5.29e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.42e-06	5.07e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.4e-06	5.06e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.33e-06	5.01e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	7.19e-06	4.92e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.44e-06	4.4e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	6.37e-06	4.36e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—INS—Alzheimer's disease	6.32e-06	4.32e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	5.98e-06	4.09e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	5.92e-06	4.05e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	5.83e-06	3.99e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	5.61e-06	3.83e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.54e-06	3.79e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	5.42e-06	3.7e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	5.38e-06	3.68e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.07e-06	3.46e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	5e-06	3.42e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.55e-06	1.74e-05	CbGpPWpGaD
